Ann: Update to TGA Submission, page-159

I have sent an email to the company asking them, very courteously, to provide more detail on exactly what this "analytical testing" actually means in regards the 3 production batches that will be requested from Biotem, in particular whether it involves also re-testing a cohort of people with the kits or whether its just a laboratory test for consistency and uniformity of the kits in regards the constituent biochemical species which comprise the test kit. I requested that since many shareholders would like to be informed on this matter, if a reply could be given as an update briefing via an ASX announcement. I believe this is a reasonable request and am not asking for in-depth detail, just a heads-up on what is involved in broad terms. This much we are owed as owners of the company ( aka shareholders)